home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
Solution Page

Forum
Forum sources  
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
 

Ethical challenges of genome editing - Ethics review identifies top two challenges for genome editing


London, United Kingdom
September 30, 2016

Source: King’s College London

nuffield_wide-banner-aw

Preventing the transmission of inherited genetic diseases, and increasing food production rates in farmed animals are two potential applications of genome editing technologies that require urgent ethical scrutiny, according to a new report by the Nuffield Council on Bioethics.

The Council, which includes academics from King's, has today published the first findings of its review looking at the potential impact of recent advances in genome editing such as the CRISPR-Cas9 system across many areas of biological research. The report found evidence that, given its technical advantages and rates of uptake, genome editing is already having an almost unprecedented impact in research. The Council considered the possible effects of these advances in fields such as health care, food production, industry and public health.

Professor Karen Yeung, Director of the Centre for Technology, Law & Society at King’s and a member of the Nuffield Council on Bioethics Working Group, who conducted the review said: ‘We examined the way in which these technologies are being taken up in the research community and what we found is that, because of a number of advantages which they offer in relation to existing techniques for manipulating DNA, they are having an unprecedented transformative effect on the biological sciences and for that reason they have the potential to change our expectations and ambitions about human control over the biological world.

‘One of the reasons why we are undertaking this review is to encourage public deliberation. We think that the potential applications for human health are very important, but also in relation to food production where the technology is really almost ready to go and that is why we are trying to think carefully about the ethical dimensions in order to try and identify the paths of development that we think are the most ethically appropriate.’

The Council will now begin work on two further inquiries addressing the ethical and practical questions raised by possible uses of genome editing in different fields. The first of these will focus on the potential use of genome editing in human reproduction to avoid the transmission of heritable genetic conditions, and the second on livestock to improve systems of animal husbandry and food production.

Dr Andy Greenfield, Chair of the Nuffield Council on Bioethics Working Group who conducted the review, said:‘Genome editing is already showing a potential to transform not only how biological research is carried out, but more importantly our expectations and ambitions for addressing challenges such as disease prevention and food security. Although most uses so far have been in research, the potential applications seem to be almost unlimited, given that the techniques are applicable to all organisms, from bacteria to plants, animals, and human beings.’

Avoiding genetic disease

Human reproductive applications are probably the most talked about potential application of genome editing technologies and raise some of the most complex ethical concerns. Genome editing could one day offer an alternative approach to preventing the inheritance of diseases such as cystic fibrosis.

Concerns have been stirred by reports of research in China to correct disease-causing genetic mutations in non-viable embryos in 2015 and the granting, by the Human Fertilisation and Embryology Authority (HFEA), of a licence to allow genome editing of embryos in the UK February 2016.

Professor Yeung is Chair of the newly established Nuffield Council on Bioethics Working Party on human reproductive applications and said: ‘Genome editing is a potentially powerful set of techniques that holds many future possibilities, including that of altering certain genetic features at the embryonic stage that are known to lead to serious and life-limiting disease. In the UK and in many other countries, a long path to legislative change would have to be followed before this could become a treatment option. But it is only right that we acknowledge where this new science may lead and explore the possible paths ahead to ensure the one on which we set out today is the right one. We will be very interested to hear people’s views on this aspect of genome editing technologies in our new inquiry.’ 

Many people have concerns about the possible use of genome editing in humans, for example, about the risks of unintended effects due to off target DNA alterations, and the implications of making irreversible changes that will be passed on to future generations. Another key concern is the possible orientation of research towards human enhancement, going beyond disease prevention into the engineering of ‘desirable’ genetic characteristics. As with other technologies and innovations, the potential benefits and harms of genome editing might not be distributed equitably, and some people are worried that negative effects could cause discrimination, injustice or disadvantage to certain individuals or groups.


The report is available on the Nuffield Council for Bioethics website: Genome editing:an ethical review

 

nuffield_wide-banner-aw

The Council published Genome editing: an ethical review on 30 September 2016

Download the full review

Download the short guide, or start reading here:

  1. Introduction to the review
  2. Genome editing in brief: what, why and how?
  3. The context of genome editing
  4. Moral perspectives
  5. Human health
  6. Food
  7. Wildlife and ecosystems
  8. Other applications: industrial, military and amateur use
  9. Conclusions

The review was carried out by an interdisciplinary Working Group that included expertise in science, law, philosophy, ethics, sociology and industry. In coming to its conclusions, the Working Group invited contributions from a wide range of people, including through an open call for evidence that ran from November 2015 until February 2016.



Published: October 6, 2016



SeedQuest does not necessarily endorse the factual analyses and opinions
presented on this Forum, nor can it verify their validity.


Copyright @ 1992-2024 SeedQuest - All rights reserved